Department of Physiology, Augusta University, Augusta, Georgia, USA.
Am J Hypertens. 2018 Nov 13;31(12):1247-1254. doi: 10.1093/ajh/hpy148.
While it has been known since the 1940s that men have greater increases in blood pressure (BP) compared with women, there have been intense efforts more recently to increase awareness that women are also at risk for developing hypertension and that cardiovascular diseases (CVDs) are the leading causes of death among both men and women in the United States. With the release of the 2017 Hypertension Clinical Guidelines, 46% of adults in the United States are now classified as hypertensive, and hypertension is the primary modifiable risk factor for the development of CVD. This increase in the prevalence of hypertension is reflected in an increase in prevalence among both men and women across all demographics, although there were greater increases in the prevalence of hypertension among men compared with women. As a result, the well-established gender difference in the prevalence of hypertension is even more pronounced and now extends into the sixth decade of life. The goals of this review are to (i) review the historical clinical trial data and hypertension guidelines from the perspective of both genders and then (ii) review the role of the renin-angiotensin system and T-cell activation in contributing to sex differences in BP control.
虽然早在 20 世纪 40 年代就已经知道男性的血压(BP)升高幅度大于女性,但最近人们越来越意识到女性也有患高血压的风险,并且心血管疾病(CVDs)是导致美国男女死亡的主要原因。随着 2017 年高血压临床指南的发布,美国现在有 46%的成年人被归类为高血压患者,高血压是 CVD 发展的主要可改变风险因素。高血压的流行率增加反映在所有人群中男性和女性的流行率都有所增加,尽管男性的高血压流行率增加幅度大于女性。因此,高血压流行率中已经确立的性别差异更加明显,现在甚至延伸到第六个十年的生命。本综述的目的是(i)从两性的角度回顾历史临床试验数据和高血压指南,然后(ii)综述肾素-血管紧张素系统和 T 细胞激活在导致血压控制性别差异方面的作用。